Collectively, our findings highlight the complex interplay between insulin signaling, metabolic dysfunction, and cognitive health, underscoring the potential for therapeutic strategies impacting these pathways to mitigate the impacts of cognitive aging and AD. Here, INS is linked to Alzheimer disease.